Financial Ratios

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis
BSE1788.45-3.45 (-0.19 %)
PREV CLOSE ( ) 1791.90
OPEN PRICE ( ) 1784.65
BID PRICE (QTY) 1787.00 (3)
OFFER PRICE (QTY) 1789.40 (14)
VOLUME 2205
TODAY'S LOW / HIGH ( )1774.30 1798.45
52 WK LOW / HIGH ( )1209.25 1935
NSE1786.9015.25 (+0.86 %)
PREV CLOSE( ) 1771.65
OPEN PRICE ( ) 1780.00
BID PRICE (QTY) 1786.35 (19)
OFFER PRICE (QTY) 1786.90 (2)
VOLUME 64358
TODAY'S LOW / HIGH( ) 1773.10 1797.85
52 WK LOW / HIGH ( )1209.25 1933.5
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)27.1338.9935.7322.1320.22
   CEPS(Rs)43.7250.7744.3028.2223.30
   DPS(Rs)8.008.008.008.0013.26
   Book NAV/Share(Rs)181.34161.69128.39100.7982.27
   Tax Rate(%)22.3526.5224.5619.9631.99
Margin Ratios
   Core EBITDA Margin(%)25.4728.0329.6326.4625.37
   EBIT Margin(%)19.7225.5926.3622.5526.25
   Pre Tax Margin(%)16.7923.4725.1921.0425.67
   PAT Margin (%)13.0317.2519.0016.8417.46
   Cash Profit Margin (%)21.0022.4523.5521.4820.11
Performance Ratios
   ROA(%)8.3614.8919.9314.2615.07
   ROE(%)15.8226.9031.3124.2826.18
   ROCE(%)19.8733.6043.0531.7438.29
   Asset Turnover(x)0.640.861.050.850.86
   Sales/Fixed Asset(x)0.861.492.922.832.98
   Working Capital/Sales(x)87.6217.462.413.955.63
Efficiency Ratios
   Fixed Capital/Sales(x)1.160.670.340.350.34
   Receivable days45.6542.7448.3966.5762.82
   Inventory Days15.1113.4310.5510.1810.87
   Payable days139.42132.35124.33116.7082.10
Valuation Parameters
   PER(x)46.0352.2362.7258.120.00
   PCE(x)28.5740.1250.5945.570.00
   Price/Book(x)6.8912.6017.4512.760.00
   Yield(%)0.640.390.360.62
   EV/Net Sales(x)6.049.1311.529.590.00
   EV/Core EBITDA(x)21.8031.0337.2731.070.01
   EV/EBIT(x)30.6135.6843.7142.540.01
   EV/CE(x)3.916.2911.077.670.00
   M Cap / Sales6.009.0111.929.790.00
Growth Ratio
   Net Sales Growth(%)-7.8620.3544.5014.4719.85
   Core EBITDA Growth(%)-13.2914.5644.7022.2510.44
   EBIT Growth(%)-28.9916.8568.93-1.6710.43
   PAT Growth(%)-30.369.2463.0010.455.95
   EPS Growth(%)-30.429.1261.459.46-79.85
Financial Stability Ratios
   Total Debt/Equity(x)0.090.310.000.000.04
   Current Ratio(x)1.041.192.802.101.56
   Quick Ratio(x)0.901.062.631.981.46
   Interest Cover(x)6.7212.0722.4914.9945.34
   Total Debt/Mcap(x)0.010.020.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.